Orthobiology Articles & Analysis
16 news found
” “We are thrilled by the addition of ExsoMed to the extensive Acumed portfolio of innovative upper extremity, lower extremity, CMF, tendon, ligament, and orthobiologics solutions to better serve our customers worldwide,” said Hjalmar Pompe van Meerdervoort, President of Acumed. ...
Isto Biologics, a leader in surgical-based, orthobiologic regeneration technologies and cell-based therapies, announced today the launch of Influx™ Fibrant, an unprecedented line of functional constructs derived from 100% cortical allograft. ...
Isto Biologics, a leader in surgical-based, orthobiologic regeneration technologies and cell-based therapies, announced today that it has acquired TheraCell, Inc., a California-based regenerative medicine company. ...
Cervos Medical's best-in-class autologous and synthetic orthobiologic products mimic and promote vasculogenesis, the body's natural reparative mechanism. ...
BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announced that the company has submitted a supplementary De Novo application to the US Food and Drug Administration (FDA) to obtain a market approval for the company’s antibiotic-releasing product CERAMENT® G. ...
CARLSBAD, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced it received simultaneous CE Mark certification for its Cranial Module and Percutaneous Spine Module for the 7D FLASH™ Navigation System. This achievement expands the ...
Funding to further advance Locate Bio’s regenerative medicine pipeline of orthobiologics Locate Bio, an orthobiologics focused regenerative medicine company, is pleased to announce that it has raised an oversubscribed £10 million of equity investment in a funding round co-led by existing shareholder Mercia Asset Management and new investor BGF. ...
CARLSBAD, Calif., July 07, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the FDA 510(k) clearance of its 7D Percutaneous Spine Module for minimally invasive surgery. This represents a new application and increased functionality for its 7D Flash™ ...
"Leveraging our expertise in machine-vision, intelligent software and advanced optics, with SeaSpine's comprehensive implant and orthobiologics portfolio provides a clear pathway for us to expand our reach inside and outside of the operating room as a newly combined company and to service the larger continuum of care in treating patients throughout their entire surgical journey." ...
BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, has been awarded a group purchasing agreement for Synthetic Implantable Products with Premier. ...
The Company’s second FDA Breakthrough Device designation granted in 2021 Locate Bio, an orthobiologics focused regenerative medicine company, is pleased to announce that the U.S. ...
FDA’s Breakthrough Device Program helps accelerate patient access to more effective treatments Locate Bio, an orthobiologics focused regenerative medicine company, is pleased to announce that the U.S. ...
Another important step towards its ambition of building a world leading, diversified orthobiologics company Locate Bio, an orthobiologics focused regenerative medicine company, is pleased to announce the appointment of Keith Valentine as the Non-Executive Chair of the Board with immediate effect. ...
Jointechlabs plans to focus on a range of therapeutic areas including medical aesthetics, plastic surgery, orthobiologics and wound healing. “The FDA clearance of MiniTC represents an important step forward in the regenerative medicine market,” said Nathan Katz, Jointechlabs’ CEO. ...
Locate Bio, an orthobiologics focused regenerative medicine company, today announced the in-licencing of multiple late stage orthobiologics assets from RCSI University of Medicine and Health Sciences. ...
This is an exciting technology that for Heraeus Medical, as a pure-play orthobiologics company, will allow us to expand our regenerative market ...